A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China

Bulletin of the World Health Organization

Volumn 86, Issue 10, 2008, Pages 788-795

  Hou, Xun Ya ^a   McManus, Donald P ^b   Gray, Darren J ^b   Balen, Julie ^b   Luo, Xin Song ^a   He, Yong Kang ^a   Ellis, Magda ^b   Williams, Gail M ^c   Li, Yue Sheng ^b  

^a HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; PLACEBO; PRAZIQUANTEL; PREDNISONE;

BLOOD; CHEMOTHERAPY; COMPARATIVE STUDY; DRUG DEVELOPMENT; ENZYME; HEALTH MONITORING; HEALTH SERVICES; HEALTH SURVEY; HEMOGLOBIN; SCHISTOSOMIASIS; TEMPORAL ANALYSIS;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; ALLERGY; ARTICLE; CHINA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; LENGTH OF STAY; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SCHOOL CHILD; SINGLE DRUG DOSE; UPPER ABDOMINAL PAIN; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTHELMINTICS; ARTEMISININS; CHILD; CHINA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PRAZIQUANTEL; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMICIDES; YOUNG ADULT;

ASIA; CHINA; DONGTING LAKE; EURASIA; FAR EAST; HUNAN;

JAPONICA;

EID: 54249153209     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.053041     Document Type: Article

References (31)

1. Minggang C, Zheng F. Schistosomiasis control in China. Parasitol Int 1999;48:11-9.
2. Zhou XN, Wang LY, Chen MG, Wu XH, Jiang QW, Chen XY, et al. The public health significance and control of schistosomiasis in China - then and now. Acta Trop 2005;96:97-105.
3. Balen J, Zhao ZY, Williams GM, McManus DP, Raso G, Utzinger J, et al. Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China. Bull World Health Organ 2007;85:519-526.
4. Yuan H, Guo JG, Bergquist R, Tanner M, Chen XY, Wang HZ. The 1992-1999 World Bank schistosomiasis research initiative in China: outcome and perspectives. Parasitol Int 2000;49:195-207.
5. Qing-Wu J, Li-Ying W, Jia-Gang G, Ming-Gang C, Xiao-Nong Z, Engels D. Morbidity control of schistosomiasis in China. Acta Trop 2002;82:115-25.
6. Ross AGP, Sleigh AC, Li YS, Davis GM, Williams GM, Zheng J, et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001;14:270-95.
7. Utzinger J, Zhou XN, Chen MG, Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop 2005;96:69-96.
8. Li YS, Raso G, Zhao ZY, He YK, Ellis MK, McManus DP. Large water management project and schistosomiasis control, Dongting Lake region, China. Emerg Infect Dis 2007;13:973-9.
9. Li YS, Sleigh AC, Ross AGP, Li Y, Williams GM, Forsyth SJ, et al. A 2-year prospective study in China provides epidemiological evidence for resistance in humans to re-infection with Schistosoma japonicum. Ann Trop Med Parasitol 1999;93:629-42.
10. McManus DP, Bartley PB. A vaccine against Asian schistosomiasis. Parasitol Int 2004;53:163-73.
11. Finkelstein JL, Schleinitz MD, Carabin H, McGarvey ST. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature. PLoS Negl Trop Dis 2008;2:e158.
12. Ross AGP, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis 2007;7:218-24.
13. Ministry of Public Health of China. Manual for schistosomiasis control [in Chinese]. 3rd ed. Shanghai: Publishing House for Science and Technology; 2001. pp. 58-61.
14. Chen MG. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop 2005;96:168-76.
15. Xiao SH, Yue WJ, Yang YQ, You JQ. Susceptibility of Schistosoma japonicum of different developmental stages to praziquantel. Chin Med J (Engl) 1987;100:759-68.
16. Wang SR, Shi W, Zhou ZW. Treatment of schistosomiasis with praziquantel: report of 93 cases [in Chinese]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2004;16:264-8.
17. Le WJ, You JQ, Yang YQ, Mei JY, Guo HF, Yang HZ, et al. Studies on the efficacy of artemether in experimental schistosomiasis [in Chinese]. Yao Xue Xue Bao 1982;17:187-93.
18. Xiao SH, Catto BA. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 1989;33:1557-62.
19. Xiao SH, You JQ, Yang Y, Wang CZ. Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asian J Trop Med Public Health 1995;26:306-18.
20. Utzinger J, Xiao SH, Keiser J, Chen MG, Zheng J, Tanner M. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr Med Chem 2001;8:1841-60.
21. Xiao S, Tanner M, N'Goran EK, Utzinger J, Chollet J, Bergquist R, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 2002;82:175-81.
22. Xiao S, Shi ZG, Zhuo SJ, Wang CZ, Zhang ZG, Chu B, et al. Field studies on the preventive effect of oral artemether against schistosomal infection. Chin Med J (Engl) 1996;109:272-5.
23. Tian ZY, Xiao SH, Xiao JW, Zhou YC, Liu DS, Zheng J, et al. Reduction of Schistosoma japonicum infection in an endemic area in islet with embankment after prophylaxis with oral artemether throughout the transmission season [in Chinese]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Bing Bing Za Zhi 1997;15:208-11.
24. Wang JL, Xiao SH, Yang Z, Wang MK, Yang H, Liu YH, et al. Effect of oral artemether in controllong schistosomaisis in Yunnan mountainous endemic area [in Chinese]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Bing Bing Za Zhi 1997;15:138-43.
25. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao SH, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomized controlled trial. Lancet 2000;355:1320-5.
26. N'Goran EK, Utzinger J, Gnaka HN, Yapi A, N'Guessan NA, Kigbafori SD, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg 2003;68:24-32.
27. Li YS, Chen HG, He HB, Hou XY, Ellis M, McManus DP. A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Trop 2005;96:184-90.
28. ShuHua X, Jiqing Y, Jinying JM, Huifang G, Peiying J, Tanner M. Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits. Parasitol Int 2000;49:25-30.
29. Utzinger J, Chollet J, You JQ, Mei JY, Tanner M, Xiao SH. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 2001;80:9-18.
30. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14:397-400.
31. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 2007;8:105-16.